← Evidence map

ArticleBiomedicines2022

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.

Martina Catalano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36289706